SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
2.19
-0.02 (-0.90%)
At close: Aug 15, 2025, 3:59 PM
2.21
0.91%
After-hours: Aug 15, 2025, 07:52 PM EDT
SAB Biotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -40.05M | -34.28M | -34.11M | -45.57M | -40.32M | -39.87M | -42.19M | -25.62M | -27.59M | -25.48M | -17.14M | -28.45M | -19.4M | -17.57M | -17.14M | 440.23K | -1.53M | 1.41M |
Depreciation & Amortization | 4.08M | 3.55M | 4.76M | 4.92M | 4.94M | 4.81M | 3.75M | 2.09M | 2.01M | 1.9M | 1.65M | 2.37M | 1.88M | 1.39M | 994.06K | 992.41K | 577.37K | 277.22K |
Stock-Based Compensation | 3.58M | 2.94M | 2.94M | 2.8M | 2.4M | 2.44M | 2.42M | 2.52M | 2.45M | 2.38M | 2.67M | 2.05M | 2.35M | 2.21M | 1.67M | 1.66M | 782.55K | 349.12K |
Other Working Capital | 446.97K | -221.13K | -3.39M | -1.2M | -4.3M | -4.46M | 18.5K | 7.11M | 9.37M | 7.31M | 3.92M | 10.45M | 5.7M | 7.19M | 11.87M | -1.43M | 2.33M | 2.94M |
Other Non-Cash Items | -602.16K | -5.16M | -5.82M | 2.78M | 2.63M | 5.02M | 10.75M | 13.72M | 13.13M | 11.35M | 3.48M | -1.79M | -2.85M | -1.11M | 6.08M | -2.5M | -667.1K | -665.6K |
Deferred Income Tax | n/a | n/a | n/a | -2.53M | -2.53M | -2.17M | -2.17M | 357.52K | 357.52K | n/a | n/a | -0.00 | -0.00 | -0.00 | -0.00 | n/a | n/a | n/a |
Change in Working Capital | 2.22M | 1.54M | -2.3M | -842.05K | -4.43M | -4.66M | 2.33M | 23.05M | 22.75M | 23.42M | 14.22M | 7.22M | 5.26M | 381.37K | 13.45M | 150.67K | 3.91M | 8.08M |
Operating Cash Flow | -30.77M | -31.41M | -34.53M | -38.44M | -37.32M | -34.43M | -25.12M | 15.76M | 12.76M | 13.21M | 4.52M | -18.6M | -14.05M | -15.99M | 3.76M | -553.34K | 3.07M | 9.45M |
Capital Expenditures | -155.68K | -208.19K | -337.26K | -349.75K | -334.75K | -304.93K | -197.15K | -9.02M | -9.02M | -9.61M | -10.94M | 3.3M | 155.32K | -2.7M | -3.23M | -8.58M | -5.35M | -1.89M |
Cash Acquisitions | 500.00 | 500.00 | n/a | n/a | 44.45K | 44.45K | 44.45K | 44.45K | n/a | n/a | 76.39K | 76.39K | 76.39K | 76.39K | n/a | n/a | n/a | n/a |
Purchase of Investments | -6.3M | -6.29M | -37.45M | -36.14M | -31.34M | -31.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -116.15M | -116.15M | -116.15M | -116.15M |
Sales Maturities Of Investments | 29.18M | 30.56M | 25.82M | 15.13M | 11.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -5.01M | -337.26K | -337.26K | n/a | n/a | n/a | n/a | -76.39K | -76.39K | -76.39K | n/a | 99.93M | -10.87M | -10.87M | -10.94M | -110.8M | n/a | n/a |
Investing Cash Flow | 18.05M | 24.07M | -11.96M | -21.36M | -20.25M | -31.49M | -152.7K | -9.06M | -9.09M | -9.68M | -10.94M | 103.23M | -7.48M | -10.33M | -10.94M | -116.15M | -5.35M | -1.89M |
Debt Repayment | 154.01K | 75.52K | n/a | -671.13K | -164.74K | -276.2K | -390.44K | -1.93M | -1.82M | -2.26M | -1.95M | -958.37K | -977.43K | -223.47K | -324.72K | -247.46K | -196.23K | -150K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.52M | -5.52M | -5.52M | -5.52M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -938.59K | -938.59K | -936.52K | -25K | n/a | n/a | 1.89K | 1.89K | 1.89K | 71.03K | 76.97K | 34.63M | 152.06M | 151.99M | 152.09M | 117.53M | 104.53K | 104.53K |
Financial Cash Flow | -805K | -883.48K | -936.52K | 66.48M | 67.02M | 66.91M | 66.77M | 38.82M | 38.93M | 38.56M | 33.36M | -89.49M | 27.92M | 28.6M | 34.12M | 117.29M | -91.7K | -45.47K |
Net Cash Flow | -8.67M | -8.39M | -47.67M | 6.75M | 9.47M | 974.08K | 41.52M | 18.59M | 15.66M | 15.15M | n/a | 7.66M | 6.38M | 2.28M | 26.93M | -11.94M | -2.38M | 7.52M |
Free Cash Flow | -38.26M | -31.62M | -34.87M | -38.79M | -37.65M | -34.74M | -25.32M | 6.74M | 3.74M | 3.6M | -6.42M | -15.3M | -13.9M | -18.68M | 530.46K | -9.14M | -2.29M | 7.56M |